SEATTLE, WA - September 29, 2021 - Proprio, the Seattle medical device company enabling surgeons to perform complex procedures through the combination of computer vision, machine learning, and immersive technology, is pleased to share that Dr. Christopher Shaffrey, MD, FACS has joined its Medical Advisory Board. A world-renowned leader in both neurological and orthopaedic surgery, Dr. Shaffrey brings extensive industry experience and insight to Proprio’s MAB at the height of the company’s development towards its Series B fundraising round.
“At Proprio, we are creating the new way of seeing. Our vision for the future of medicine is one in which surgeons harness the most advanced technologies to deliver ever improving results,” emphasizes Gabriel Jones, CEO and Co-founder of Proprio. “We’re working with world-class physicians, engineers, and computer scientists to design an intelligent operating system for surgery built around our Proprio Paradigm System. I couldn’t be more excited to welcome Dr. Shaffrey and his invaluable expertise to our Medical Advisory Board.”
“I’m honored to join Proprio’s Medical Advisory Board,” said Dr. Shaffrey. “They are fundamentally influencing how surgery can be performed to optimize outcomes for both patients and surgeons, and I look forward to being involved at such a critical time. Proprio has such immense potential to positively impact the work my colleagues and I do every day.”
Dr. Christopher Shaffrey
Christopher I. Shaffrey, MD, FAANS graduated magna cum laude from The Citadel in 1982 with B.S. degree in biology. He played varsity basketball and was the co-captain his senior year. In 1986, Shaffrey received his medical degree from the University of Virginia. He completed his general surgical internship at Naval Hospital San Diego in 1987 where he was named the surgical intern of the year. He then completed both neurosurgical and orthopaedics residencies at the University of Virginia, followed by a spine fellowship in pediatric and adult reconstructive spine surgery in 1995. Following completion of his surgical training, he was appointed to the senior staff in the departments of neurological surgery and orthopaedic surgery at Detroit’s Henry Ford Hospital where he was actively involved in treating members of Detroit’s college and professional athletic teams. In 1999, Shaffrey was appointed associate professor of neurological surgery and adjunct associate professor of orthopaedic surgery and sports medicine at the University of Washington in Seattle. In 2003, he returned to the University of Virginia as professor of neurological surgery and director of the neurosurgery spine division. In 2008, he was named Harrison Distinguished Teaching Professor of Neurological and Orthopaedic Surgery. In July of 2018, Dr. Shaffrey was named the chief of the Duke Spine Division for the departments of Orthopaedic Surgery and Neurological Surgery and is a tenured professor of Orthopaedic and Neurological Surgery.
Dr. Shaffrey is Board-certified in the fields of neurological surgery and orthopaedic surgery and has more than 450 peer-reviewed publications and more than 1000 national and international presentations. He has served or is serving as the Deputy Editor of the journals Spine and Spine Deformity and has served as the Chair of the Editorial Board for JNS: Spine as well as being an editor for several textbooks on spinal surgery. He has been the Chair of the ABNS and is currently a member of the Neurosurgery Residency Review Committee. He is the past president of the American Association of Neurological Surgeons and the president elect for the Scoliosis Research Society.
To learn more about Proprio and its medical advisors, visit www.propriovision.com.
Proprio is developing a new type of surgical imaging and navigation system which provides a dramatic enhancement of the surgeon’s vision. The Proprio Paradigm system integrates recent advancements in robotics, computer vision, and graphics processing to enable surgeons to see and interact with patients as never before, reduce the complexity of surgical procedures, and create a valuable new visual data set to enhance medical training and drive healthcare innovation. The company is backed by leading healthcare and technology investors, including DCVC (Data Collective), BOLD Capital Partners, Cota Capital, Intel, HTC, and Alan Frazier, founder of Frazier Healthcare Partners. For more information visit www.propriovision.com.
November 3, 2020